| Lyanne Marie Caraballo, PA | |
|
1000 Integrity Dr Ste 110, Pittsburgh, PA 15235-3332 | |
| (412) 342-0036 | |
| (412) 342-0041 |
| Full Name | Lyanne Marie Caraballo |
|---|---|
| Gender | Female |
| Speciality | Physician Assistant |
| Experience | 6 Years |
| Location | 1000 Integrity Dr Ste 110, Pittsburgh, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003394545 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Adventhealth Orlando | Orlando, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Florida Hospital Medical Group Inc | 0749186153 | 1163 |
News Archive
A chip-scale device that both produces and detects a specialized gas used in biomedical analysis and medical imaging has been built and demonstrated at the National Institute of Standards and Technology (NIST).
Researchers at the University of North Carolina at Chapel Hill and partners have found strong evidence that rates of heat-related illnesses, such as heat cramps and heat strokes, were reduced by half in states that had mandated guidelines to reduce exertional heat illness among high school football players.
Examination of a gene involved in cell signaling finds that four common variants of this gene are associated with the development of end-stage renal disease in Chinese patients with type 2 diabetes, according to a study in the August 25 issue of JAMA.
After years of struggling with costs that were eating into his bottom line, David White, a small business owner in Maine, recently dropped health insurance for himself and his employees. It was a nerve-wracking decision (Sen. Mary Landrieu, D-La., 10/8).
Teva Pharmaceutical Industries Ltd., today announced up to 7-year efficacy, safety and tolerability results from the Glatiramer Acetate Low-Frequency Administration (GALA) open-label extension study of COPAXONE (glatiramer acetate injection) 40 mg/mL administered subcutaneously three-times-a-week for the treatment of relapsing forms of multiple sclerosis (RMS).
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Lyanne Marie Caraballo, PA 5200 Centre Ave Ste 312, Pittsburgh, PA 15232-1302 Ph: (412) 621-7777 | Lyanne Marie Caraballo, PA 1000 Integrity Dr Ste 110, Pittsburgh, PA 15235-3332 Ph: (412) 342-0036 |
News Archive
A chip-scale device that both produces and detects a specialized gas used in biomedical analysis and medical imaging has been built and demonstrated at the National Institute of Standards and Technology (NIST).
Researchers at the University of North Carolina at Chapel Hill and partners have found strong evidence that rates of heat-related illnesses, such as heat cramps and heat strokes, were reduced by half in states that had mandated guidelines to reduce exertional heat illness among high school football players.
Examination of a gene involved in cell signaling finds that four common variants of this gene are associated with the development of end-stage renal disease in Chinese patients with type 2 diabetes, according to a study in the August 25 issue of JAMA.
After years of struggling with costs that were eating into his bottom line, David White, a small business owner in Maine, recently dropped health insurance for himself and his employees. It was a nerve-wracking decision (Sen. Mary Landrieu, D-La., 10/8).
Teva Pharmaceutical Industries Ltd., today announced up to 7-year efficacy, safety and tolerability results from the Glatiramer Acetate Low-Frequency Administration (GALA) open-label extension study of COPAXONE (glatiramer acetate injection) 40 mg/mL administered subcutaneously three-times-a-week for the treatment of relapsing forms of multiple sclerosis (RMS).
› Verified 9 days ago